18. Sharma R K, Edwards K, Hallett C, et al. Perception Among Paediatric Patients of the Diskus® Inhaler, a Novel Multidose Powder Inhaler for Use in the Treatment of Asthma[J]. Clinical Drug Investigation, 1996, 11(3):145-153. 责任编辑:子凌 题...
16. Pedersen S, Maspero J, Gul N, Sharma R. Components of asthma control and treatment response of individual control criteria in children: analysis of the PEACE study. Pediatr Pulmonol, 2011, 46(12):1182-8. 17. Hill L S, Slater A L. A comparison of the performance of two modern mul...
Background: As Canada's population ages, the location of end of life care (whether at home, extended care facility or hospital) may change depending on the location of death. We carried out a study to identify determinants of the place of death. Methods: Data on deaths in British Columbia...
Mild asthma causes a substantial burden with respect to risk of exacerbations [1]. This risk can be reduced with the use of inhaled glucocorticoid therapy [2]. This treatment is often not used due to health care professional reluctance to prescribe and patient reluctance to take it when their ...
[6] LiPet all. Omalizumab Treatment Patterns Among Patients with Asthma in the US Medicare Population. JAllergy Clin Immunol Pract. 2020 Feb; 8(2): 507-515.e10. [7] B Sposato, et al. Effects of omalizumab in severe asthmatics across ages: A real life Italian experience. Respir Med....
The goal of asthma treatment, to achieve and maintain clinical control, can be reached in a majority of patients ho, a) with a pharmacologic intervention strategy developed in partnership between the patient/family and the doctor. Each patient is assigned to one of five " treatment steps ...
The Global Initiative for Asthma recommends a stepwise approach to adjust asthma treatment to the needs of individual patients; inhaled corticosteroids (ICS) remain the core pharmacological treatment. However, many patients remain poorly controlled, and evidence-based algorithms to decide on the best ord...
THURSDAY, June 28, 2018 (HealthDay News) -- Compared to treatment with an inhaled glucocorticoid alone, combination therapy with a long-acting ?2-agonist (LABA) and an inhaled glucocorticoid is not associated with a significantly higher risk of serious asthma-related events, according to a study...
27、gonists as a single controlling medication for asthma (strong recommendation/moderate-quality evidence). 哮喘伴有过敏性鼻炎患者,使用一种控制药物时,推荐ICS 优先于口服白三烯受体拮抗剂(强推荐/中等质量证据)注:鼻内糖皮质激素不用于治疗哮喘症状,但可用于哮喘合并鼻炎患者治疗鼻炎症状AR:过敏性鼻炎AIRA 2010...
Maintenance treatment with an inhaled corticosteroid (ICS) and a long-acting β2-agonist (LABA) is recommended for patients whose asthma is not controlled with a low-to-moderate dose of ICS alone; a separate reliever medication is used on an as-needed basis. The Gaining Optimal Asthma ControL...